Status:
COMPLETED
Primovist Post-marketing Surveillance in Japan
Lead Sponsor:
Bayer
Conditions:
Diagnostic Imaging
Eligibility:
All Genders
Brief Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Primovist for contrast enhancement in MRI of liver....
Eligibility Criteria
Inclusion
- Patients who received Primovist for liver MRI
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
March 11 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2015
Estimated Enrollment :
2030 Patients enrolled
Trial Details
Trial ID
NCT01411449
Start Date
March 11 2008
End Date
February 18 2015
Last Update
March 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Japan